Cargando…
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy
Autores principales: | Wang, Di, Mao, Xia, Que, Yimei, Xu, Menglei, Cheng, Yuhang, Huang, Liang, Wang, Jue, Xiao, Yi, Wang, Wen, Hu, Guang, Zhang, Shangkun, Zhang, Tongcun, Li, Chunrui, Zhou, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521092/ https://www.ncbi.nlm.nih.gov/pubmed/34663791 http://dx.doi.org/10.1038/s41408-021-00563-8 |
Ejemplares similares
-
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia
por: Li, Chunrui, et al.
Publicado: (2021) -
Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report
por: Li, Dan, et al.
Publicado: (2022) -
Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials
por: Que, Yimei, et al.
Publicado: (2021) -
Single VHH-directed BCMA CAR-NK cells for multiple myeloma
por: Ren, Quan, et al.
Publicado: (2023) -
Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma
por: Xu, Jinhuan, et al.
Publicado: (2018)